Cancer cells can develop resistance to antineoplastic antibiotics, making them less effective over time. This can occur through various mechanisms, such as increased drug efflux, enhanced DNA repair, or alterations in drug targets. To combat resistance, these drugs are often used in combination with other chemotherapy agents or targeted therapies.
